Categories
Jagsonpal Pharmaceuticals Limited — Updates, 27-04-2026: Press Release
27-04-2026 · 07:54 pm
Jagsonpal Pharma's Q4 revenue rose 10% to ₹64.2 Cr, PAT surged 31% to ₹8.8 Cr. FY26 revenue hit ₹287.2 Cr (+7%), PAT ₹44.6 Cr (+19%). Board approved a ₹40 Cr buyback and proposed 200% dividend totaling ₹26.2 Cr. Strong cash position at ₹191 Cr, outpacing IPM growth.
No comments yet. Be the first to comment!